Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Veteran's herpes simplex virus II and atopic dermatitis were found to meet the criteria for a 60 percent rating from December 21, 2011 to February 18, 2016.

The deciding factor: The VA examiner noted that the Veteran's herpes simplex virus II involved more than 40 percent of the total body area and required constant or near-constant systemic therapy including oral immunosuppressant medication over the past 12-month period.

Claimed conditions
Herpes Simplex Virus II, Atopic Dermatitis
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
60%
Decision date
October 5, 2022
Citation
A22020317

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A22020317.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.